Tysabri monotherapy and progressive multifocal leukoencephalopathy
The FDA has recently received information from the manufacturer about two new cases of progressive multifocal leukoencephalopathy (PML) in patients
Read MoreFaulty Pharmaceutical Drugs Resources
The FDA has recently received information from the manufacturer about two new cases of progressive multifocal leukoencephalopathy (PML) in patients
Read More